Are Antiemetics the Next Therapeutic Strategy against Cisplatin-Associated Acute Kidney Injury?
作者信息
Motwani Shveta S, Abudayyeh Ala
机构信息
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
MD Anderson Cancer Center, University of Texas, Houston, Texas.
出版信息
Kidney360. 2024 Aug 1;5(8):1067-1068. doi: 10.34067/KID.0000000000000518.
Abstract
摘要
相似文献
1
Are Antiemetics the Next Therapeutic Strategy against Cisplatin-Associated Acute Kidney Injury?止吐药会成为对抗顺铂相关急性肾损伤的下一种治疗策略吗？
Kidney360. 2024 Aug 1;5(8):1067-1068. doi: 10.34067/KID.0000000000000518.
2
Is oral ondansetron really efficacious in the control of cisplatin-induced delayed emesis?口服昂丹司琼在控制顺铂引起的迟发性呕吐方面真的有效吗？
J Clin Oncol. 1996 Apr;14(4):1401-2. doi: 10.1200/JCO.1996.14.4.1401.
3
[Emesis induced by cisplatin and sulfato-1, sulfato-1,2-diaminocyclohexane platinum in dogs and their antiemetics].[顺铂和1-硫酸根、1,2-二氨基环己烷铂诱导犬呕吐及其止吐药]
Zhongguo Yao Li Xue Bao. 1986 Mar;7(2):182-4.
4
The control of delayed nausea.延迟性恶心的控制
Ann Oncol. 1997 Jun;8(6):615-6. doi: 10.1023/a:1017186721738.
5
Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin.使用NK1受体拮抗剂预防顺铂后的迟发性呕吐。
J Natl Cancer Inst. 1997 Jun 4;89(11):817-8. doi: 10.1093/jnci/89.11.817.
6
Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference.化疗和放疗引起的恶心和呕吐的预防：佩鲁贾共识会议指南更新及结果
Support Care Cancer. 2011 Mar;19 Suppl 1:S63-5. doi: 10.1007/s00520-010-1044-1. Epub 2010 Dec 28.
7
Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.托烷司琼联合与不联合地塞米松对比大剂量甲氧氯普胺预防顺铂所致急性和迟发性恶心呕吐的前瞻性随机对照研究
Am J Clin Oncol. 1999 Apr;22(2):126-30. doi: 10.1097/00000421-199904000-00004.
8
Clinical trials referral resource. Cancer chemoprevention and control trials.临床试验转诊资源。癌症化学预防与控制试验。
Oncology (Williston Park). 1996 Apr;10(4):499-500.
9
Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03).理气和中汤对接受基于顺铂方案治疗的子宫体癌或宫颈癌患者化疗引起的恶心和呕吐的疗效——安慰剂对照、双盲、随机验证性研究（JORTC-KMP03）
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251329346. doi: 10.1177/15347354251329346. Epub 2025 Mar 29.
10
Using aprepitant as secondary antiemetic prophylaxis for cancer patients with cisplatin-induced emesis.采用阿瑞匹坦作为顺铂致吐的癌症患者的二线止吐预防药物。
Support Care Cancer. 2012 Oct;20(10):2357-61. doi: 10.1007/s00520-011-1345-z. Epub 2011 Dec 21.
本文引用的文献
1
Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective Analysis.评价同时使用抗血清素受体拮抗剂与顺铂的患者的急性肾损伤：一项回顾性分析。
Kidney360. 2024 Aug 1;5(8):1094-1100. doi: 10.34067/KID.0000000000000464. Epub 2024 May 30.
2
Kidney and Mortality Outcomes Associated with Ondansetron in Critically Ill Patients.与危重症患者使用昂丹司琼相关的肾脏和死亡结局。
J Intensive Care Med. 2022 Oct;37(10):1403-1410. doi: 10.1177/08850666211073582. Epub 2022 Jan 8.
3
Effect of ondansetron on reducing ICU mortality in patients with acute kidney injury.昂丹司琼对降低急性肾损伤患者 ICU 死亡率的影响。
Sci Rep. 2021 Sep 30;11(1):19409. doi: 10.1038/s41598-021-98734-x.
4
Effects of ondansetron use on outcomes of acute kidney injury in critically ill patients: An analysis based on the MIMIC-IV database.基于 MIMIC-IV 数据库的分析：昂丹司琼使用对危重症患者急性肾损伤结局的影响。
J Crit Care. 2021 Dec;66:117-122. doi: 10.1016/j.jcrc.2021.07.015. Epub 2021 Sep 9.
5
Effects of 5-HT receptor antagonists on cisplatin-induced kidney injury.5-HT 受体拮抗剂对顺铂诱导的肾损伤的影响。
Clin Transl Sci. 2021 Sep;14(5):1906-1916. doi: 10.1111/cts.13045. Epub 2021 Jun 2.
Zotero 插件